Corporate Updates

Sun Pharma acquires Pola Pharma to boost dermatology segment

Sun Pharma

Sun Pharma recently made an announcement to acquire Japan-based Pola Pharma. The deal, which will help Sun Pharma to strengthen its presence in dermatology segment across the globe, was struck for $1 million.


Sun PharmaThe firm has entered into a definitive agreement to acquire Pola Pharma, which is engaged in research and development, manufacture, sale and distribution of branded and generic products in Japan, Sun Pharma said.

Pola Pharma’s portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama, with capabilities to manufacture topical products and injectables.


Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top